NCT00927940View on ClinicalTrials.gov

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

February 28, 2015

Conditions
Arterial Occlusive DiseasesMyocardial IschemiaCardiovascular DiseasesCoronary Artery Disease
Interventions
DEVICE

MDT-4107 Drug Eluting Stent

Implantation of a MDT-4107 Zotarolimus-Eluting Coronary Stent

Trial Locations (14)

441-8530

Toyohashi Heart Center, Aichi

041-8680

Hospital Hakodate Hokkaido, Hokkaido

660-8511

Kansai Rosai Hospital, Hyōgo

211-8510

Kanto Rosai Hospital, Kanagawa

230-0012

Yokohama Tobu Hospital, Kanagawa

247-8533

Shonan Kamakura General Hospital, Kanagawa

866-8533

Kumamoto Rosai Hospital, Kumamoto

615-8256

Kyoto Katsura Hospital, Kyoto

710-8602

Kurashiki Central Hospital, Okayama

329-0498

Jichi Medical University Hospital, Tochigi

106-0032

The Cardiovascular Institute Hospital, Tokyo

142-8666

Showa University Hospita, Tokyo

153-6181

Toho University Medical Center, Ohashi Hospital, Tokyo

173-8606

Teikyo University Hospital, Tokyo

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
collaborator

Medtronic Japan Co., Ltd.

INDUSTRY

lead

Medtronic Vascular

INDUSTRY

NCT00927940 - RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent | Biotech Hunter | Biotech Hunter